ARLENE MORRIS
Equibles does not estimate personal net worth.
About ARLENE MORRIS
ARLENE MORRIS was last confirmed as Board Member at Edgewise Therapeutics, Inc. (EWTX) in a filing dated April 29, 2025. Edgewise Therapeutics, Inc. reported in an 8-K filed May 7, 2024 that ARLENE MORRIS was appointed Class I director, effective May 6, 2024.
“On May 6, 2024, the Board of Directors (the “Board”) of Edgewise Therapeutics, Inc. (the “Company”) appointed Arlene Morris to serve (i) as a Class I director, with a term expiring at the Company’s 2025 annual meeting of stockholders, (ii) as a member of the Audit Committee of the Board (the “Audit Committee”), and (iii) as a member of the Compensation Committee of the Board (the “Compensation Committee”), replacing Peter Thompson as a member of the Audit Committee and Compensation Committee.”
Affiliation history
-
Start not stated–2025-04-29
Last confirmed by a filing; no departure on record